Dermatologic Therapy

SJR Rank #6,962H-index: 90SJR: 0.796Best quartile: Q1APC: US$2,700Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

John Wiley and Sons Inc

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • DermatologyQ1
  • Medicine (miscellaneous)Q2

Areas: Medicine

Most published research topics

Dermatology and Skin DiseasesAutoimmune Bullous Skin DiseasesDermatologic Treatments and ResearchPsoriasis: Treatment and PathogenesisNail Diseases and Treatmentsmelanin and skin pigmentationHair Growth and DisordersCutaneous lymphoproliferative disorders researchUrticaria and Related ConditionsAcne and Rosacea Treatments and Effects

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs02505007501000

Documents per Year

202220250200400600800

Detailed Information

ISSN

1396-0296, 1529-8019

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

1.01

References per Document

40.88

Coverage

1996-2026

Scope

Dermatologic Therapy has been created to fill an important void in the dermatologic literature: the lack of a readily available source of up-to-date information on the treatment of specific cutaneous diseases and the practical application of specific treatment modalities. Each issue of the journal consists of a series of scholarly review articles written by leaders in dermatology in which they describe, in very specific terms, how they treat particular cutaneous diseases and how they use specific therapeutic agents. The information contained in each issue is so practical and detailed that the reader should be able to directly apply various treatment approaches to daily clinical situations. Because of the specific and practical nature of this publication, Dermatologic Therapy not only serves as a readily available resource for the day-to-day treatment of patients, but also as an evolving therapeutic textbook for the treatment of dermatologic diseases.

Metrics from SCImago Journal Rank 2025. View on SCImago